Cited by 2,542Cancer Genomics and DiagnosticsCancer Cells and MetastasisMicrofluidic and Bio-sensing Technologies

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases

Allard, W. Jeffrey, Matera, Jeri, Miller, M. Craig, Repollet, Madeline, Connelly, Mark C., Rao, Chandra, Tibbe, Arjan G. J., Uhr, Jonathan W., Terstappen, Leon W. M. M.·2004·Clinical Cancer Research

DOI 10.1158/1078-0432.ccr-04-0378

Published version of a preprint

Open this paper in CoChat — free account

Abstract

PURPOSE: The purpose of this study was to determine the accuracy, precision, and linearity of the CellSearch system and evaluate the number of circulating tumor cells (CTCs) per 7.5 mL of blood in healthy subjects, patients with nonmalignant diseases, and patients with a variety of metastatic carcinomas. EXPERIMENTAL DESIGN: The CellSearch system was used to enumerate CTCs in 7.5 mL of blood. Blood samples spiked with cells from tumor cell lines were used to establish analytical accuracy, reproducibility, and linearity. Prevalence of CTCs was determined in blood from 199 patients with nonmalignant diseases, 964 patients with metastatic carcinomas, and 145 healthy donors. RESULTS: Enumeration of spiked tumor cells was linear over the range of 5 to 1,142 cells, with an average recovery of >/=85% at each spike level. Only 1 of the 344 (0.3%) healthy and nonmalignant disease subjects had >/=2 CTCs per 7.5 mL of blood. In 2,183 blood samples from 964 metastatic carcinoma patients, CTCs ranged from 0 to 23,618 CTCs per 7.5 mL (mean, 60 +/- 693 CTCs per 7.5 mL), and 36% (781 of 2,183) of the specimens had >/=2 CTCs. Detection of >/=2 CTCs occurred at the following rates: 57% (107 of 188) of prostate cancers, 37% (489 of 1,316) of breast cancers, 37% (20 of 53) of ovarian cancers, 30% (99 of 333) of colorectal cancers, 20% (34 of 168) of lung cancers, and 26% (32 of 125) of other cancers. CONCLUSIONS: The CellSearch system can be standardized across multiple laboratories and may be used to determine the clinical utility of CTCs. CTCs are extremely rare in healthy subjects and patients with nonmalignant diseases but present in various metastatic carcinomas with a wide range of frequencies.

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-04-0378

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · PEDIATRICS · doi:10.1542/peds.65.1.187 · Cited by 14,736
Statistics for Experimenters
Addelman, S., Box, G. E. P., Hunter, W. G., & Hunter, J. S. (1979) · Technometrics · doi:10.2307/1267766 · Cited by 6,753
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,602
Detection and characterization of carcinoma cells in the blood
Racila, E. V., Euhus, D., Weiss, A. J., Rao, C., McConnell, J. D., Terstappen, L. W. M. M., & Uhr, J. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4589 · Cited by 713
Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques [see comments]
Ross, A., Cooper, B., Lazarus, H. M., Mackay, W., Moss, T., Ciobanu, N., Tallman, M. S., Kennedy, M., Davidson, N., & Sweet, D. (1993) · Blood · doi:10.1182/blood.v82.9.2605.bloodjournal8292605 · Cited by 487
Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments]
Brugger, W., Bross, K., Glatt, M., Weber, F., Mertelsmann, R. H., & Kanz, L. (1994) · Blood · doi:10.1182/blood.v83.3.636.636 · Cited by 440
Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments]
Brugger, W., Bross, K., Glatt, M., et al. (1994) · Blood · doi:10.1182/blood.v83.3.636.bloodjournal833636 · Cited by 357
Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues.
Momburg, F., Moldenhauer, G., Hämmerling, G. J., & Möller, P. (1987) · PubMed · Cited by 328
Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer
Kugaya, A., Akechi, T., Okuyama, T., Nakano, T., Mikami, I., Okamura, H., & Uchitomi, Y. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12 · Cited by 309
Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells
Borgen, E., Naume, B., Nesland, J. M., Kvalheim, G., Beiske, K., Fodstad, Ø., Diel, I., Solomayer, E., Theocharous, P., Coombes, R. C., et al. (1999) · Cytotherapy · doi:10.1080/0032472031000141283 · Cited by 263

Show all 30 references

Research works printed but not linked: 8

Soria JC, Gauthier LR, Raymond E, et al Molecular detection of telomerase positive circulating epithelial cells in metastatic breast cancer patients. Clin Cancer Res 1999;5:971-5.
Fehm T, Sagalowsky A, Clifford E, et al Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res 2002;8:2073-84.
Kagan M, Howard D, Bendele T, et al A sample preparation and analysis system for identification of circulating tumor cells. J Clin Ligand Assay 2002;25:104-10.
Rao C, Rutner H, Hermann M, Russell T, Terstappen LWMM. Preservation of blood specimens to prevent breakdown of circulating tumor cells. Proc Am Assoc Cancer Res 2002;43:734
Allard WJ, Hayes DF, Repollet MI, et al A cellular preservative improves the specificity and yield of circulating tumor cells in carcinoma patients[abstract A3482]. Proc Am Soc Clin Oncol 2003;22:866
Motulsky H. The confidence interval of counted variables. Intuitive biostatistics 1995p. 245-9. Oxford University Press New York
Miller MC, Gross S, Allard WJ, et al Circulating tumor cells (CTCs) predict survival in patients with metastatic prostate cancer[abstract A5270]. Proc Am Assoc Cancer Res 2004;45:1215
Cristofanilli M, Reuben JM, Fritsche HA, et al Circulating tumor cells (CTCs): a novel prognostic factor for newly diagnosed metastatic breast cancer (MBC)[abstract A1349]. Proc Am Assoc Cancer Res 2003;44:1349

Sorted by citations

Items 801–900 of 1,004

Prognostic significance of circulating tumor cells in non-small cell lung cancer patients undergoing chemotherapy
Tong, B., Xu, Y., Zhao, J., Chen, M., Xing, J., Zhong, W., & Wang, M. (2017) · Oncotarget · doi:10.18632/oncotarget.21255 · Cited by 47
Prognostic and therapeutic significance of circulating tumor cells in patients with lung cancer
Yousefi, M., Ghaffari, P., Nosrati, R., Dehghani, S., Salmaninejad, A., Abarghan, Y. J., & Ghaffari, S. H. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00470-y · Cited by 48
Cancer-ID: Toward Identification of Cancer by Tumor-Derived Extracellular Vesicles in Blood
Rikkert, L. G., Beekman, P., Caro, J., Coumans, F. A. W., Enciso‐Martinez, A., Jenster, G. W., Gac, S. L., Lee, W., van Leeuwen, T. G. J. M., Loozen, G. B., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00608 · Cited by 47
Magnetic Particles for CTC Enrichment
Liu, P., Jonkheijm, P., Terstappen, L. W. M. M., & Stevens, M. (2020) · Cancers · doi:10.3390/cancers12123525 · Cited by 47
Inertial Microfluidics Enabling Clinical Research
Kalyan, S., Torabi, C., Khoo, H., Sung, H. W., Choi, S., Wang, W., Treutler, B., Kim, D., & Hur, S. C. (2021) · Micromachines · doi:10.3390/mi12030257 · Cited by 49
Dormant Tumor Cells Develop Cross-Resistance to Apoptosis Induced by CTLs or Imatinib Mesylate via Methylation of Suppressor of Cytokine Signaling 1
Saudemont, A., Hamrouni, A., Marchetti, P., 刘继中, Jouy, N., Hétuin, D., Colucci, F., & Quesnel, B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1627 · Cited by 54
Herceptin functionalized polyhedral oligomeric silsesquioxane – conjugated oligomers – silica/iron oxide nanoparticles for tumor cell sorting and detection
Mi, Y., Li, K., Liu, Y., Pu, K.-Y., Liu, B., & Feng, S.-S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.040 · Cited by 46
Current and future applications of liquid biopsy in non-small-cell lung cancer—a narrative review
Tomasik, B., Skrzypski, M. T., Bieńkowski, M., Dziadziuszko, R., & Jassem, J. (2023) · Translational Lung Cancer Research · doi:10.21037/tlcr-22-742 · Cited by 48
Circulating Tumor Cells in Patients Undergoing Surgery for Hepatic Metastases from Colorectal Cancer
Papavasiliou, P., Fisher, T. L., Kuhn, J. A., Nemunaitis, J. J., & Lamont, J. P. (2010) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2010.11928572 · Cited by 46
A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer
Kelley, R. K., Hwang, J. H., Magbanua, M. J. M., Watt, L., Beumer, J. H., Christner, S. M., Baruchel, S., Wu, B., Fong, L. H., Yeh, B. M., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.553 · Cited by 46
Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer
Krishnamurthy, S., Bischoff, F. Z., Mayer, J. A., Wong, K. L., Pham, T., Kuerer, H. M., Lodhi, A., Bhattacharyya, A., Hall, C. S., & Lucci, A. (2013) · Cancer Medicine · doi:10.1002/cam4.70 · Cited by 46
Laparoscopic surgery minimizes the release of circulating tumor cells compared to open surgery for hepatocellular carcinoma
Li, W., Zhou, X., Huang, Z., Zhang, H., Zhang, L., Shang, C., & Chen, Y. (2015) · Surgical Endoscopy · doi:10.1007/s00464-014-4041-5 · Cited by 46
Immunocapture of prostate cancer cells by use of anti-PSMA antibodies in microdevices
Santana, S. M., Liu, H., Bander, N. H., Gleghorn, J. P., & Kirby, B. J. (2011) · Biomedical Microdevices · doi:10.1007/s10544-011-9616-5 · Cited by 46
Detection and Prognostic Significance of Circulating Tumor Cells in Patients With Metastatic Thyroid Cancer
Xu, J. Y., Handy, B. C., Michaelis, C., Waguespack, S. G., Hu, M. I.-N., Busaidy, N. L., Jiménez, C., Cabanillas, M. E., Fritsche, H. A., Cote, G. J., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2567 · Cited by 46
Circulating tumor cells: silent predictors of metastasis
Zhou, L., Dicker, D. T., Matthew, E. M., El‐Deiry, W. S., & Alpaugh, R. K. (2017) · F1000Research · doi:10.12688/f1000research.11313.1 · Cited by 46
Blood-based biomarkers in lung cancer: prognosis and treatment decisions
Xu‐Welliver, M., & Carbone, D. P. (2017) · Translational Lung Cancer Research · doi:10.21037/tlcr.2017.09.08 · Cited by 46
Label-Free Enrichment and Molecular Characterization of Viable Circulating Tumor Cells from Diagnostic Leukapheresis Products
Franken, A., Driemel, C., Behrens, B., Meier-Stiegen, F., Endris, V., Stenzinger, A., Niederacher, D., Fischer, J., Stoecklein, N. H., Ruckhaeberle, E., et al. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2018.296814 · Cited by 46
Detection of Circulating Tumor Cells Using Membrane-Based SERS Platform: A New Diagnostic Approach for ‘Liquid Biopsy’
Kamińska, A., Szymborski, T. R., Witkowska, E., Kijeńska‐Gawrońska, E., Święszkowski, W., Niciński, K., Trzcińska‐Danielewicz, J., & Girstun, A. (2019) · Nanomaterials · doi:10.3390/nano9030366 · Cited by 46
Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now?
Pelizzaro, F., Cardin, R., Penzo, B., Pinto, E., Vitale, A., Cillo, U., Russo, F. P., & Farinati, F. (2021) · Cancers · doi:10.3390/cancers13092274 · Cited by 46
Single-cell analysis of circulating tumour cells: enabling technologies and clinical applications
Radfar, P., Es, H. A., Salomon, R., Kulasinghe, A., Ramalingam, N., Sarafraz-Yazdi, E., Thiery, J. P., & Warkiani, M. E. (2022) · Trends in biotechnology · doi:10.1016/j.tibtech.2022.02.004 · Cited by 47
The Different Facets of Liquid Biopsy: A Kaleidoscopic ViewPreprint
Eslami‐S, Z., Cortés‐Hernández, L. E., Cayrefourcq, L., & Alix‐Panabières, C. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a037333 · Cited by 48
Detection of circulating tumor cells in cancers of biliary origin.
Ustwani, O. A., Iancu, D., Yacoub, R., & Iyer, R. V. (2012) · PubMed Central · doi:10.3978/j.issn.2078-6891.2011.047 · Cited by 45
Detection of Circulating Tumor Cell Subpopulations in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
Weller, P., Nel, I., Hassenkamp, P., Gauler, T. C., Schlueter, A., Lang, S., Dountsop, P., Hoffmann, A.-C., & Lehnerdt, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113706 · Cited by 45
Isolation of circulating tumor cells by immunomagnetic enrichment and fluorescence-activated cell sorting (IE/FACS) for molecular profiling
Magbanua, M. J. M., & Park, J. W. (2013) · Methods · doi:10.1016/j.ymeth.2013.07.029 · Cited by 45
Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications
Danova, M., Torchio, M., & Mazzini, G. (2011) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.11.33 · Cited by 45
Heterogeneity of miR-10b expression in circulating tumor cells
Gasch, C., Plummer, P. N., Jovanovic, L., McInnes, L. M., Wescott, D., Saunders, C. M., Schneeweiß, A., Wallwiener, M., Nelson, C. C., Spring, K. J., et al. (2015) · Scientific Reports · doi:10.1038/srep15980 · Cited by 45
Circulating tumor cells and circulating tumor DNA: What surgical oncologists need to know?
Cabel, L., Proudhon, C., Mariani, P., Tzanis, D., Beinse, G., Bièche, I., Pierga, J., & Bidard, F. (2017) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2017.01.010 · Cited by 46
Clusters of circulating tumor cells: A biophysical and technological perspective
Au, S. H., Edd, J., Haber, D. A., Maheswaran, S., Stott, S. L., & Toner, M. (2017) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2017.08.001 · Cited by 45
Using the New CellCollector to Capture Circulating Tumor Cells from Blood in Different Groups of Pulmonary Disease: A Cohort Study
He, Y., Shi, J. F., Shi, G., Xu, X., Liu, Q., Liu, C., Gao, Z., Bai, J., & Shan, B. (2017) · Scientific Reports · doi:10.1038/s41598-017-09284-0 · Cited by 46
A Novel Workflow to Enrich and Isolate Patient-Matched EpCAMhigh and EpCAMlow/negative CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer
Lampignano, R., Yang, L., Neumann, M., Franken, A., Fehm, T. N., Niederacher, D., & Neubauer, H. J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091885 · Cited by 45
Comparison of isolation platforms for detection of circulating renal cell carcinoma cells
Maertens, Y., Humberg, V., Erlmeier, F., Steffens, S., Steinestel, J., Bögemann, M., Schrader, A. J., & Bernemann, C. (2017) · Oncotarget · doi:10.18632/oncotarget.21197 · Cited by 45
EpCAM-based assays for epithelial tumor cell detection in cerebrospinal fluid
van Bussel, M. T. J., Pluim, D., Bol, M., Beijnen, J. H., Schellens, J. H. M., & Brandsma, D. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2691-6 · Cited by 45
Embedded Disposable Functionalized Electrochemical Biosensor with a 3D-Printed Flow Cell for Detection of Hepatic Oval Cells (HOCs)
Damiati, S., Peacock, M., Leonhardt, S., Damiati, L. A., Baghdadi, M. A., Becker, H., Kodzius, R., & Schuster, B. (2018) · Genes · doi:10.3390/genes9020089 · Cited by 45
Liquid Biopsy in Primary Brain Tumors: Looking for Stardust!
Fontanilles, M., Durán-Peña, A., & Idbaïh, A. (2018) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-018-0820-z · Cited by 45
Circulating Tumor DNA for Early Cancer Detection
Fiala, C., Kulasingam, V., & Diamandis, E. P. (2018) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2018.026393 · Cited by 45
Capture and selective release of multiple types of circulating tumor cells using smart DNAzyme probes
Zhang, Q., Wang, W., Huang, S., Yu, S., Tan, T., Zhang, J., & Zhu, J. (2020) · Chemical Science · doi:10.1039/c9sc04309h · Cited by 45
Preoperative CTC-Detection by CellSearch® Is Associated with Early Distant Metastasis and Impaired Survival in Resected Pancreatic Cancer
Hugenschmidt, H., Labori, K. J., Borgen, E., Brunborg, C., Schirmer, C. B., Seeberg, L. T., Naume, B., & Wiedswang, G. (2021) · Cancers · doi:10.3390/cancers13030485 · Cited by 45
Prognostic and Predictive Roles for Circulating Biomarkers in Gastrointestinal Cancer
Mattos‐Arruda, L. D., Olmos, D., & Tabernero, J. M. (2011) · Future Oncology · doi:10.2217/fon.11.122 · Cited by 45
Pancreaticoduodenectomy and Vascular Resection: Persistent Controversy and Current Recommendations
Christians, K. K., & Evans, D. B. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0322-y · Cited by 45
Advances in Liquid Biopsy Technology and Implications for Pancreatic Cancer
Raufi, A. G., May, M. S., Hadfield, M. J., Seyhan, A. A., & El‐Deiry, W. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044238 · Cited by 47
Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis
Court, C. M., Ankeny, J. S., Hou, S., Tseng, H., & Tomlinson, J. S. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1091311 · Cited by 44
Personalized Treatment of Lung Cancer
Salgia, R., Hensing, T. A., Campbell, N. P., Salama, A. K. S., Maitland, M. L., Hoffman, P. C., Villaflor, V. M., & Vokes, E. E. (2011) · Seminars in Oncology · doi:10.1053/j.seminoncol.2011.01.012 · Cited by 43
Lung cancer stem cells: a biological and clinical perspective
Koren, A., Motaln, H., & Čufer, T. (2013) · Cellular Oncology · doi:10.1007/s13402-013-0141-9 · Cited by 44
Computational Analysis of Enhanced Magnetic Bioseparation in Microfluidic Systems with Flow-Invasive Magnetic Elements
Khashan, S. A., Alazzam, A., & Furlani, E. P. (2014) · Scientific Reports · doi:10.1038/srep05299 · Cited by 44
Prognostic value of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: a systematic review and meta-analysis
Wang, Z., Cui, K., Xue, Y., Tong, F., & Li, S. (2015) · Medical Oncology · doi:10.1007/s12032-015-0579-x · Cited by 44
Circulating Tumor Cells Measurements in Hepatocellular Carcinoma
Chiappini, F. (2012) · International Journal of Hepatology · doi:10.1155/2012/684802 · Cited by 44
Circulating tumor cells: A promising marker of predicting tumor response in rectal cancer patients receiving neoadjuvant chemo-radiation therapy
Sun, W., Li, G., Wan, J., Zhu, J. Y., Shen, W., & Zhang, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.10875 · Cited by 44
Clinical Implications and Future Perspectives of Circulating Tumor Cells and Biomarkers in Clinical Outcomes of Colorectal Cancer
Huang, M., Tsai, H., Huang, J., & Wang, J. (2016) · Translational Oncology · doi:10.1016/j.tranon.2016.06.006 · Cited by 44
Prismatic Deflection of Live Tumor Cells and Cell Clusters
Aldridge, P. M., Mukhopadhyay, M., Ahmed, S. U., Zhou, W., Christinck, E. R., Makonnen, R., Sargent, E. H., & Kelley, S. O. (2018) · ACS Nano · doi:10.1021/acsnano.8b07616 · Cited by 44
Aptamer-based nanostructured interfaces for the detection and release of circulating tumor cells
Ding, P., Wang, Z., Wu, Z., Zhu, W., Liu, L., Sun, N., & Pei, R. (2020) · Journal of Materials Chemistry B · doi:10.1039/c9tb02457c · Cited by 44
Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer
Dirix, L. Y., Buys, A., Oeyen, S., Peeters, D. J. E., Liègeois, V., Prové, A., Rondas, D., Vervoort, L., Mariën, V., Laere, S. V., et al. (2022) · Breast Cancer Research and Treatment · doi:10.1007/s10549-022-06585-5 · Cited by 44
Biomarkers for early diagnosis of pancreatic cancer
Jenkinson, C., Earl, J., Ghaneh, P., Halloran, C., Carrato, A., Greenhalf, W., Neoptolemos, J., & Costello, E. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.965145 · Cited by 42
Effective Capture of Circulating Tumor Cells from a Transgenic Mouse Lung Cancer Model Using Dendrimer Surfaces Immobilized with Anti-EGFR
Myung, J. H., Roengvoraphoj, M., Tam, K. A., Ma, T., Memoli, V. A., Dmitrovsky, E., Freemantle, S. J., & Hong, S. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b02766 · Cited by 43
Circulating Tumor Cells
Hayes, D. F., & Smerage, J. B. (2010) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385071-3.00005-8 · Cited by 44
Microfluidics for the detection of minimal residual disease in acute myeloid leukemia patients using circulating leukemic cells selected from blood
Jackson, J. M., Taylor, J. B., Witek, M. A., Hunsucker, S. A., Waugh, J. P., Fedoriw, Y. D., Shea, T. C., Soper, S. A., & Armistead, P. M. (2015) · The Analyst · doi:10.1039/c5an01836f · Cited by 43
Biosensors for the Detection of Circulating Tumour Cells
Costa, C., Abal, M., López‐López, R., & Muinelo‐Romay, L. (2014) · Sensors · doi:10.3390/s140304856 · Cited by 43
Circulating tumor cells as pharmacodynamic biomarker in early clinical oncological trials
Devriese, L. A., Voest, E. E., Beijnen, J. H., & Schellens, J. H. M. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.04.006 · Cited by 45
Development of a method to isolate circulating tumor cells using mesenchymal-based capture
Bitting, R. L., Boominathan, R., Rao, C., Kemeny, G., Foulk, B., García-Blanco, M. A., Connelly, M. C., & Armstrong, A. J. (2013) · Methods · doi:10.1016/j.ymeth.2013.06.034 · Cited by 43
Cellular and molecular aspects of pancreatic cancer
Gharibi, A., Adamian, Y., & Kelber, J. A. (2016) · Acta Histochemica · doi:10.1016/j.acthis.2016.01.009 · Cited by 43
Nanotheranostic approaches for management of bloodstream bacterial infections
Jagtap, P., Sritharan, V., & Gupta, S. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.09.005 · Cited by 43
A magnetic micropore chip for rapid (<1 hour) unbiased circulating tumor cell isolation and in situ RNA analysis
Ko, J., Bhagwat, N., Yee, S. S., Black, T. A., Redlinger, C., Romeo, J., O’Hara, M. H., Raj, A., Carpenter, E. L., Stanger, B. Z., et al. (2017) · Lab on a Chip · doi:10.1039/c7lc00703e · Cited by 44
The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities
Tesfaye, A. A., Kamgar, M., Azmi, A. S., & Philip, P. A. (2017) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2018.1417844 · Cited by 43
Multivalent Binding and Biomimetic Cell Rolling Improves the Sensitivity and Specificity of Circulating Tumor Cell Capture
Myung, J. H., Eblan, M. J., Caster, J. M., Park, S.-J., Poellmann, M. J., Wang, K., Tam, K. A., Miller, S., Shen, C. J., Chen, R. C., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3078 · Cited by 43
Self-seeding circulating tumor cells promote the proliferation and metastasis of human osteosarcoma by upregulating interleukin-8
Liu, T., Ma, Q., Zhang, Y., Wang, X., Xu, K., Kang, Y., Dong, W., Fan, Q., Zhang, Y., & Qiu, X. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1795-7 · Cited by 43
The current status of the clinical utility of liquid biopsies in cancer
Snow, A. E., Chen, D., & Lang, J. E. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1664290 · Cited by 44
Pre-Analytical and Analytical Variables of Label-Independent Enrichment and Automated Detection of Circulating Tumor Cells in Cancer Patients
Koch, C., Joosse, S. A., Schneegans, S., Wilken, O. J. W., Janning, M., Loreth, D., Müller, V., Prieske, K., Banys-Paluchowski, M. J., Horst, L. J., et al. (2020) · Cancers · doi:10.3390/cancers12020442 · Cited by 43
AFP mRNA level in enriched circulating tumor cells from hepatocellular carcinoma patient blood samples is a pivotal predictive marker for metastasis
Jin, J., Niu, X., Zou, L., Li, L., Li, S., Han, J., Zhang, P., Song, J., & Xiao, F. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.04.033 · Cited by 43
Multistage microfluidic cell sorting method and chip based on size and stiffness
Li, G., Ji, Y., Wu, Y., Liu, Y., Liu, Y., Wang, Y., Chi, M., Sun, H., & Zhu, H. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115451 · Cited by 43
Long term survival following the detection of circulating tumour cells in head and neck squamous cell carcinoma
Winter, S. C., Stephenson, S., Subramaniam, S. K., Paleri, V., Ha, K. O., Marnane, C. N., Krishnan, S., & Rees, G. L. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-424 · Cited by 42
Circulating tumour cells in prostate cancer patients receiving salvage radiotherapy
Lowes, L. E., Lock, M. I., Rodrigues, G., D'Souza, D. P., Bauman, G. S., Ahmad, B., Venkatesan, V., Allan, A. L., & Sexton, T. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0775-5 · Cited by 42
Circulating Tumor Cell Analysis in Metastatic Triple-Negative Breast Cancers
Magbanua, M. J. M., Carey, L., DeLuca, A. N., Hwang, J., Scott, J. H., Rimawi, M. F., Mayer, E. L., Marcom, P. K., Liu, M., Esteva, F. J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1948 · Cited by 42
Capture and Release of Cancer Cells Based on Sacrificeable Transparent MnO2 Nanospheres Thin Film
Huang, Q., Chen, B., He, R., He, Z., Cai, B., Xu, J., Qian, W., Chan, H. L. W., Liu, W., Guo, S., et al. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201300670 · Cited by 42
Real-time RT-PCR systems for CTC detection from blood samples of breast cancer and gynaecological tumour patients (Review)
Andergassen, U., Kölbl, A. C., Mahner, S., & Jeschke, U. (2016) · Oncology Reports · doi:10.3892/or.2016.4608 · Cited by 42
Circulating Biomarkers for Prediction of Treatment Response
Cappelletti, V., Appierto, V., Tiberio, P., Fina, E., Callari, M., & Daidone, M. G. (2015) · JNCI Monographs · doi:10.1093/jncimonographs/lgv006 · Cited by 43
Multiscale Segmentation via Bregman Distances and Nonlinear Spectral Analysis
Zeune, L. L., van Dalum, G., Terstappen, L. W. M. M., van Gils, S. A., & Brüne, C. (2017) · SIAM Journal on Imaging Sciences · doi:10.1137/16m1074503 · Cited by 42
Second-line pazopanib in patients with relapsed and refractory small-cell lung cancer: a multicentre phase II study of the Hellenic Oncology Research Group
Koinis, F., Agelaki, S., Karavassilis, V., Kentepozidis, N. K., Samantas, E., Peroukidis, S., Katsaounis, P., Hartabilas, E., Varthalitis, I. I., Messaritakis, I., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.137 · Cited by 42
Removal of Cells from Body Fluids by Magnetic Separation in Batch and Continuous Mode: Influence of Bead Size, Concentration, and Contact Time
Bohmer, N., Demarmels, N., Tsolaki, E., Gerken, L. R. H., Keevend, K., Bertazzo, S., Lattuada, M., & Herrmann, I. K. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b10140 · Cited by 42
Detection of circulating tumor cells in liquid biopsy from Ewing sarcoma patients
Benini, S., Gamberi, G., Cocchi, S., Garbetta, J., Alberti, L., Righi, A., Gambarotti, M., Picci, P., & Ferrari, S. M. (2018) · Cancer Management and Research · doi:10.2147/cmar.s141623 · Cited by 45
Entrapment of Prostate Cancer Circulating Tumor Cells with a Sequential Size-Based Microfluidic Chip
Ren, X., Foster, B. M., Ghassemi, P., Strobl, J. S., Kerr, B. A., & Agah, M. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b01134 · Cited by 43
Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter
Watanabe, M., Kenmotsu, H., Ko, R., Wakuda, K., Ono, A., Imai, H., Taira, T., Naito, T., Murakami, H., Abe, M., et al. (2018) · Cancer Science · doi:10.1111/cas.13692 · Cited by 42
EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy
Du, F. L., Fujii, T., Kida, K., Davis, D. W., Park, M., Liu, D. D., Wu, W., Chávez‐MacGregor, M., Barcenas, C. H., Valero, V., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229903 · Cited by 42
Analysis of Released Circulating Tumor Cells During Surgery for Non-Small Cell Lung Cancer
Tamminga, M., de Wit, S., Wauwer, C. V. D., van den Bos, H., Swennenhuis, J. F., Klinkenberg, T. J., Hiltermann, T. J. N., Andree, K., Spierings, D. C. J., Lansdorp, P. M., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2541 · Cited by 41
Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes
Yang, W.-Y., Feng, L., Meng, X. L., Chen, R., Xu, W.-H., Hou, J., Xu, T., & Zhang, L. (2020) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1855977 · Cited by 42
Preinduction cervical ripening. A randomized trial of intravaginal misoprostol alone vs. a combination of transcervical Foley balloon and intravaginal misoprostol.
Rust, O. A., Greybush, M., Atlas, R., Jones, K. J., & Balducci, J. (2001) · PubMed · Cited by 42
Automated electrorotation shows electrokinetic separation of pancreatic cancer cells is robust to acquired chemotherapy resistance, serum starvation, and EMT
Lannin, T. B., Su, W.-W., Gruber, C. N., Cardle, I. I., Huang, C., Thege, F. I., & Kirby, B. J. (2016) · Biomicrofluidics · doi:10.1063/1.4964929 · Cited by 42
Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas
Adams, D. L., Adams, D. K., Stefansson, S., Haudenschild, C., Martin, S. S., Charpentier, M., Chumsri, S., Cristofanilli, M., Tang, C.-M., & Alpaugh, R. K. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0706-4 · Cited by 40
Detection of Circulating Tumor Cells in Patients With Adrenocortical Carcinoma: A Monocentric Preliminary Study
Pinzani, P., Scatena, C., Salvianti, F., Corsini, E., Canu, L., Poli, G., Paglierani, M., Piccini, V., Pazzagli, M., Nesi, G., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1396 · Cited by 41
Prognostic value of circulating tumour cells for early recurrence after resection of colorectal liver metastases
Lalmahomed, Z. S., Mostert, B., Onstenk, W., Kraan, J., Ayez, N., Gratama, J. W., Grünhagen, D. J., Verhoef, C. K., & Sleijfer, S. (2015) · British Journal of Cancer · doi:10.1038/bjc.2014.651 · Cited by 41
SELEX Aptamer Used as a Probe to Detect Circulating Tumor Cells in Peripheral Blood of Pancreatic Cancer Patients
Zhang, J., Li, S., Liu, F., Zhou, L., Shao, N., & Zhao, X. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121920 · Cited by 41
Isolation of Rare Tumor Cells from Blood Cells with Buoyant Immuno-Microbubbles
Shi, G., Cui, W., Benchimol, M. J., Liu, Y.-T., Mattrey, R. F., Mukthavaram, R., Kesari, S., Esener, S. C., & Simberg, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058017 · Cited by 41
Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer
Reyes, E. E., VanderWeele, D. J., Isikbay, M., Duggan, R., Campanile, A., Stadler, W. M., Griend, D. J. V., & Szmulewitz, R. Z. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0313-z · Cited by 41
Quantification of cellular volume and sub-cellular density fluctuations: comparison of normal peripheral blood cells and circulating tumor cells identified in a breast cancer patient
Phillips, K. G., Kolatkar, A. R., Rees, K. J., Rigg, R. A., Marrinucci, D. C., Luttgen, M. S., Bethel, K. J., Kühn, P., & McCarty, O. J. T. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00096 · Cited by 41
Nanostructured Surfaces to Target and Kill Circulating Tumor Cells While Repelling Leukocytes
Mitchell, M. J., Castellanos, C. A., & King, M. R. (2012) · Journal of Nanomaterials · doi:10.1155/2012/831263 · Cited by 41
Cytokeratin 20 improves the detection of circulating tumor cells in patients with colorectal cancer
Welinder, C., Jansson, B., Lindell, G., & Wenner, J. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.12.024 · Cited by 41
Development of a Novel c-MET–Based CTC Detection Platform
Zhang, T., Boominathan, R., Foulk, B., Rao, C., Kemeny, G., Strickler, J. H., Abbruzzese, J. L., Harrison, M. R., Hsu, D. S., Healy, P. N., et al. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0011 · Cited by 41
MINDEC-An Enhanced Negative Depletion Strategy for Circulating Tumour Cell Enrichment
Lapin, M., Tjensvoll, K., Oltedal, S., Buhl, T., Gilje, B., Smaaland, R., & Nordgård, O. (2016) · Scientific Reports · doi:10.1038/srep28929 · Cited by 41
Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer
Lowes, L. E., Goodale, D. B., Xia, Y., Postenka, C. O., Piaseczny, M. M., Paczkowski, F., & Allan, A. L. (2016) · Oncotarget · doi:10.18632/oncotarget.12682 · Cited by 41
Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients
Kohli, M., Li, J., Du, M., Hillman, D. W., Dehm, S. M., Tan, W. W., Carlson, R. E., Campion, M. B., Wang, L., Wang, L., et al. (2018) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-018-0043-z · Cited by 43
Fluidic shear stress increases the anti-cancer effects of ROS-generating drugs in circulating tumor cells
Regmi, S., Fung, T. S., Lim, S., & Luo, K. Q. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4922-8 · Cited by 41
Classification of Cells in CTC-Enriched Samples by Advanced Image Analysis
de Wit, S., Zeune, L. L., Hiltermann, T. J. N., Groen, H. J. M., van Dalum, G., & Terstappen, L. W. M. M. (2018) · Cancers · doi:10.3390/cancers10100377 · Cited by 41

Authors: Allard, W. J., Matera, J., Miller, M. C., Repollet, M., Connelly, M. C., Rao, C., Tibbe, A. G. J., Uhr, J. W., & Terstappen, L. W. M. M.
Affiliations: 1Immunicon Corporation, Huntingdon Valley, Pennsylvania; and
The University of Texas Southwestern Medical Center (US)
ORCID: Miller, M. Craig
Terstappen, Leon W. M. M.
Venue: Clinical Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2004-10-15
Volume: 10
Issue: 20
Pages: 6897-6904
ISSN: 1078-0432 (ISSN-L)
1557-3265
DOI: 10.1158/1078-0432.ccr-04-0378
OpenAlex: W2116483002
Cited by: 2,542
References: 30
Citations by year: 2026: 66 · 2025: 81 · 2024: 87 · 2023: 135 · 2022: 117 · 2021: 158 · 2020: 169 · 2019: 166 · 2018: 171 · 2017: 193 · 2016: 197 · 2015: 165 · 2014: 177 · 2013: 161 · 2012: 132
FWCI: 7.52
Type: journal article
Language: en
Open access: closed
Locations: Clinical Cancer Research (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Bio-sensing Technologies
Keywords: circulating tumor cells, CellSearch, metastatic carcinoma, prostate cancer, breast cancer, ovarian cancer, colorectal cancer, lung cancer, liquid biopsy
MeSH terms: Adult, Automation, Biological Assay, Carcinoma, Cytological Techniques, Female, Humans, Male, Middle Aged, Neoplastic Cells, Circulating, Neoplasm Metastasis, Sensitivity and Specificity, Reproducibility of Results, Case-Control Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks